BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

17 related articles for article (PubMed ID: 510896)

  • 1. Increasing human serum ribonuclease activity is a concomitant phenomenon of ovarian carcinoma.
    Schleich HG; Wiest W
    J Cancer Res Clin Oncol; 1980; 97(3):307-14. PubMed ID: 7440630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of plasma ribonuclease as a marker for gynecologic tumors and breast tumors].
    Kraus H; Deinert S
    Geburtshilfe Frauenheilkd; 1986 Jan; 46(1):20-2. PubMed ID: 3956957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes of plasma ribonuclease activities according to the method of treatment in gynecologic cancer patients (author's transl)].
    Sugawara S
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Oct; 33(10):1749-56. PubMed ID: 7310199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum ribonuclease activity in gynecologic neoplasms. The behavior of serum ribonuclease in ovarian cancer under cytostatic therapy].
    Schleich HG; Wiest W
    Fortschr Med; 1980 Sep; 98(36):1384-6. PubMed ID: 7461546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of the plasma ribonuclease activity as a diagnostic aid in the diagnosis of ovarian cancer. Results of a double blind study (author's transl)].
    Wolf A; Vahrson H; Hoss M
    Geburtshilfe Frauenheilkd; 1979 Jun; 39(6):497-502. PubMed ID: 478263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enzyme levels and carcinoma treatment. 1. The serum beta-glucuronidase activity in patients with malignant gynecologic diseases before, during and after the clinical treatment].
    Möbius W; Müller W; Carol W; Bonow A
    Arch Geschwulstforsch; 1967; 30(1):5-41. PubMed ID: 5592891
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serum ribonuclease activity in patients with gynaecologic malignomas (author's transl)].
    Schleich HG; Wiest W
    Geburtshilfe Frauenheilkd; 1979 Nov; 39(11):940-6. PubMed ID: 510896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The progress of ALDH-1 in gynecologic oncology.
    Liu L; Yi J; Zhang D
    Eur J Gynaecol Oncol; 2014; 35(5):508-12. PubMed ID: 25423694
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.